Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
2.180
-0.140 (-6.03%)
At close: Sep 12, 2025, 4:00 PM EDT
2.190
+0.010 (0.46%)
After-hours: Sep 12, 2025, 7:27 PM EDT
Phio Pharmaceuticals Market Cap
Phio Pharmaceuticals has a market cap or net worth of $12.48 million as of September 12, 2025. Its market cap has increased by 356.12% in one year.
Market Cap
12.48M
Enterprise Value
1.71M
1-Year Change
356.12%
Ranking
Category
Stock Price
$2.18
Market Cap Chart
Since May 10, 2012, Phio Pharmaceuticals's market cap has decreased from $42.54T to $12.48M, a decrease of -100.00%. That is a compound annual growth rate of -67.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 12.48M | 300.35% |
| Dec 31, 2024 | 3.12M | 67.92% |
| Dec 29, 2023 | 1.86M | -63.48% |
| Dec 30, 2022 | 5.08M | -62.43% |
| Dec 31, 2021 | 13.53M | -12.96% |
| Dec 31, 2020 | 15.55M | 146.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.94B |
| Johnson & Johnson | 429.89B |
| AbbVie | 389.03B |
| UnitedHealth Group | 320.26B |
| AstraZeneca | 251.66B |
| Novartis AG | 247.58B |
| Novo Nordisk | 241.70B |
| Abbott Laboratories | 230.87B |